Word_Press_@dmin_mibl

The EDB Act is empowered to issue an Investment Certificate and a Premium Investment Certificate. Depending on the Economic Activity, the Investment Certificate confers a set of incentives while the Premium Investment Certificate is issued according to requested incentives by the promoter and as may be approved. The certificates are only issued after submission of …

EDB Guidelines regarding issue of Investment Certificate Read More »

In 2022, a Technical Committee was set up, under the chairmanship of the Financial Secretary, to submit recommendations for the development of hi-tech pharmaceutical industry in Mauritius to a Ministerial Committee chaired by the Hon. Prime Minister. The 5 main recommendations of the Technical Committee are as follows : First, to devise a new legislative …

Recommendations of the Technical Committee on Biotechnology and Pharma Manufacturing Industry Read More »

Budget Speech 2020/21 Facilitating emergence of New Sectors: Cote D’Or Data Technology Park Pharmaceutical Industry (in context of COVID-19 pandemic) Priority investment in the Manufacturing of Pharmaceutical products, Medical Devices, Personal Protective Equipment through PPP Incentives to setting up of Medical R&D centres & CROs Biotechnology and Pharmaceutical Manufacturing Industry: Incentives to purchase land and …

Budget Measures Announced Read More »

The EU Consultants have chart the following Roadmap for the MIBL into 3 periods namely, short term, medium term and long term. A. Short Term (1 to 2 Years) Aiming to generate an ecosystem that creates trust and ensures the sustainable existence of the Mauritian biopharmaceutical industry. The Mauritian Biopharma Industry Model (Hub or Ecosystem). …

Roadmap as chartered out by EU Consultants Read More »

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla finibus mi quis lectus ullamcorper dignissim. Pellentesque rhoncus euismod sem, ac facilisis orci gravida nec. Fusce sed quam eget velit posuere rutrum quis non metus.